Increases in Human Papillomavirus Testing Preceding Diagnosis of Cervical Precancer in 5 US States, 2008–2016

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Angela A. Cleveland ◽  
Julia W. Gargano ◽  
Marie R. Griffin ◽  
Ina U. Park ◽  
Linda M. Niccolai ◽  
...  
2008 ◽  
Vol 51 (1) ◽  
pp. 62-66 ◽  
Author(s):  
Florian Roka ◽  
Julia Roka ◽  
Andreas Trost ◽  
Horst Schalk ◽  
Christian Zagler ◽  
...  

2010 ◽  
Vol 118 (3) ◽  
pp. 146-156 ◽  
Author(s):  
Panduka Samarawardana ◽  
Donna L. Dehn ◽  
Meenakshi Singh ◽  
Douglas Franquemont ◽  
Chesney Thompson ◽  
...  

2018 ◽  
Vol 11 (1) ◽  
Author(s):  
J. N. Mbatha ◽  
H. N. Galappaththi‑Arachchige ◽  
A. Mtshali ◽  
M. Taylor ◽  
P. D. Ndhlovu ◽  
...  

2003 ◽  
Vol 127 (8) ◽  
pp. 984-990
Author(s):  
David R. Bolick

Abstract Human papillomavirus testing is becoming an integral component of cervical cancer screening. Market forces will require most laboratories that perform Papanicolaou tests to develop a system for handling human papillomavirus testing also. Data and information are presented that may facilitate laboratories when addressing the following issues in the process of developing a human papillomavirus testing service: Which methodology is the best fit for the laboratory? Is it better to develop an in-house testing service or to send it out? How do I get started? What are the financial and economic issues, and how should they be managed?


2009 ◽  
Vol 171 (2) ◽  
pp. 155-163 ◽  
Author(s):  
P. E. Castle ◽  
M. Schiffman ◽  
C. M. Wheeler ◽  
N. Wentzensen ◽  
P. E. Gravitt

Sign in / Sign up

Export Citation Format

Share Document